Serum Concentration of Vascular Endothelial Growth Factor after Bilateral Intravitreal Injection of Bevacizumab
Donghyun Wang, Kyung Seek Choi, Sung Jin Lee
Korean J Ophthalmol. 2014;28(1):32-38.   Published online 2014 Jan 21     DOI:
Citations to this article as recorded by Crossref logo
Systemic adverse events and all-cause mortality following same-session bilateral intravitreal anti-VEGF injections: a systematic review
Jakob Bjerager, Javad Hajari, Oliver Niels Klefter, Yousif Subhi, Miklos Schneider
Graefe's Archive for Clinical and Experimental Ophthalmology.2024;[Epub]     CrossRef
Durga S. Borkar, Anthony Obeid, Daniel C. Su, Philip P. Storey, Xinxiao Gao, Carl D. Regillo, Richard S. Kaiser, Sunir J. Garg, Jason Hsu
American Journal of Ophthalmology.2018; 196: 211.     CrossRef
Predictors of Outcome in Patients with Neovascular Age-Related Macular Degeneration Switched from Ranibizumab to 8-Weekly Aflibercept
Irini Chatziralli, Luke Nicholson, Eleni Vrizidou, Chysoula Koutsiouki, Deepthy Menon, Theodoros N. Sergentanis, Maria Cristina Citu, Robin Hamilton, Praveen J. Patel, Phil Hykin, Sobha Sivaprasad
Ophthalmology.2016; 123(8): 1762.     CrossRef
Regression Rates Following the Treatment of Aggressive Posterior Retinopathy of Prematurity with Bevacizumab Versus Laser: 8-Year Retrospective Analysis
Simona D. Nicoară, Anne C. Ștefănuţ, Constanta Nascutzy, Gabriela C. Zaharie, Laura E. Toader, Tudor C. Drugan
Medical Science Monitor.2016; 22: 1192.     CrossRef
A Systematic Review and Meta-Analysis on the Safety of Vascular Endothelial Growth Factor (VEGF) Inhibitors for the Treatment of Retinopathy of Prematurity
Laura Pertl, Gernot Steinwender, Christoph Mayer, Silke Hausberger, Eva-Maria Pöschl, Werner Wackernagel, Andreas Wedrich, Yosuf El-Shabrawi, Anton Haas, Mary Elizabeth Hartnett
PLOS ONE.2015; 10(6): e0129383.     CrossRef
Aortoduodenal Fistula in a Patient on Intravitreal Bevacizumab Injections
Amber N. Pepper, Mauricio O. Valenzuela, Kellee L. Oller
American Journal of Therapeutics.2015; 22(3): e75.     CrossRef
Complications of Subspecialty Ophthalmic Care: Systemic Complications from the Intravitreal Administration of Agents that Target the Vascular Endothelial Growth Factor Pathway
David J. Ramsey, Luis J. Haddock, Lucy H. Young, Dean Eliott
Seminars in Ophthalmology.2014; 29(5-6): 263.     CrossRef